The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Nucleic Acid–Based Diagnostic Market Research Report 2024
Synopsis
Nucleic acid diagnosis is a method of diagnosis of human body state and disease by using the theory and technology of molecular biology to directly investigate the existence state or defect of nucleic acid, analyze the function of nucleic acid from the nucleic acid structure, replication, transcription or translation level.Its target molecule is DNA or RNA, which reflects the structure and function of nucleic acids.The genes tested are endogenous (that is, the body's own genes) and exogenous (such as viruses, bacteria, etc.), the former is used to diagnose whether the gene has disease, the latter is used to diagnose whether there is pathogen infection.
The global Nucleic Acid–Based Diagnostic market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Nucleic Acid–Based Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nucleic Acid–Based Diagnostic.
Report Scope
The Nucleic Acid–Based Diagnostic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nucleic Acid–Based Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nucleic Acid–Based Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Agilent Technologies
Danaher Corporation
Abbott Laboratories
BD
Bio-Rad Laboratories
Roche
Illumina, Inc
Thermo Fisher Scientific Inc.
Merck KGaA
Qiagen
Segment by Type
Nucleic Acid Molecular Hybridization
Polymerase Chain Reaction
Thermostatic Amplification
Gene Sequencing
Biochip Technology
Segment by Application
Hospital
Clinical Laboratory
Research Institutions
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nucleic Acid–Based Diagnostic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Nucleic acid diagnosis is a method of diagnosis of human body state and disease by using the theory and technology of molecular biology to directly investigate the existence state or defect of nucleic acid, analyze the function of nucleic acid from the nucleic acid structure, replication, transcription or translation level.Its target molecule is DNA or RNA, which reflects the structure and function of nucleic acids.The genes tested are endogenous (that is, the body's own genes) and exogenous (such as viruses, bacteria, etc.), the former is used to diagnose whether the gene has disease, the latter is used to diagnose whether there is pathogen infection.
The global Nucleic Acid–Based Diagnostic market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Nucleic Acid–Based Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nucleic Acid–Based Diagnostic.
Report Scope
The Nucleic Acid–Based Diagnostic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nucleic Acid–Based Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nucleic Acid–Based Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Agilent Technologies
Danaher Corporation
Abbott Laboratories
BD
Bio-Rad Laboratories
Roche
Illumina, Inc
Thermo Fisher Scientific Inc.
Merck KGaA
Qiagen
Segment by Type
Nucleic Acid Molecular Hybridization
Polymerase Chain Reaction
Thermostatic Amplification
Gene Sequencing
Biochip Technology
Segment by Application
Hospital
Clinical Laboratory
Research Institutions
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nucleic Acid–Based Diagnostic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nucleic Acid–Based Diagnostic Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Nucleic Acid Molecular Hybridization
1.2.3 Polymerase Chain Reaction
1.2.4 Thermostatic Amplification
1.2.5 Gene Sequencing
1.2.6 Biochip Technology
1.3 Market by Application
1.3.1 Global Nucleic Acid–Based Diagnostic Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinical Laboratory
1.3.4 Research Institutions
1.3.5 Clinic
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nucleic Acid–Based Diagnostic Market Perspective (2019-2030)
2.2 Nucleic Acid–Based Diagnostic Growth Trends by Region
2.2.1 Global Nucleic Acid–Based Diagnostic Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Nucleic Acid–Based Diagnostic Historic Market Size by Region (2019-2024)
2.2.3 Nucleic Acid–Based Diagnostic Forecasted Market Size by Region (2025-2030)
2.3 Nucleic Acid–Based Diagnostic Market Dynamics
2.3.1 Nucleic Acid–Based Diagnostic Industry Trends
2.3.2 Nucleic Acid–Based Diagnostic Market Drivers
2.3.3 Nucleic Acid–Based Diagnostic Market Challenges
2.3.4 Nucleic Acid–Based Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nucleic Acid–Based Diagnostic Players by Revenue
3.1.1 Global Top Nucleic Acid–Based Diagnostic Players by Revenue (2019-2024)
3.1.2 Global Nucleic Acid–Based Diagnostic Revenue Market Share by Players (2019-2024)
3.2 Global Nucleic Acid–Based Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nucleic Acid–Based Diagnostic Revenue
3.4 Global Nucleic Acid–Based Diagnostic Market Concentration Ratio
3.4.1 Global Nucleic Acid–Based Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nucleic Acid–Based Diagnostic Revenue in 2023
3.5 Nucleic Acid–Based Diagnostic Key Players Head office and Area Served
3.6 Key Players Nucleic Acid–Based Diagnostic Product Solution and Service
3.7 Date of Enter into Nucleic Acid–Based Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nucleic Acid–Based Diagnostic Breakdown Data by Type
4.1 Global Nucleic Acid–Based Diagnostic Historic Market Size by Type (2019-2024)
4.2 Global Nucleic Acid–Based Diagnostic Forecasted Market Size by Type (2025-2030)
5 Nucleic Acid–Based Diagnostic Breakdown Data by Application
5.1 Global Nucleic Acid–Based Diagnostic Historic Market Size by Application (2019-2024)
5.2 Global Nucleic Acid–Based Diagnostic Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Nucleic Acid–Based Diagnostic Market Size (2019-2030)
6.2 North America Nucleic Acid–Based Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Nucleic Acid–Based Diagnostic Market Size by Country (2019-2024)
6.4 North America Nucleic Acid–Based Diagnostic Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nucleic Acid–Based Diagnostic Market Size (2019-2030)
7.2 Europe Nucleic Acid–Based Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Nucleic Acid–Based Diagnostic Market Size by Country (2019-2024)
7.4 Europe Nucleic Acid–Based Diagnostic Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nucleic Acid–Based Diagnostic Market Size (2019-2030)
8.2 Asia-Pacific Nucleic Acid–Based Diagnostic Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Nucleic Acid–Based Diagnostic Market Size by Region (2019-2024)
8.4 Asia-Pacific Nucleic Acid–Based Diagnostic Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nucleic Acid–Based Diagnostic Market Size (2019-2030)
9.2 Latin America Nucleic Acid–Based Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Nucleic Acid–Based Diagnostic Market Size by Country (2019-2024)
9.4 Latin America Nucleic Acid–Based Diagnostic Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nucleic Acid–Based Diagnostic Market Size (2019-2030)
10.2 Middle East & Africa Nucleic Acid–Based Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Nucleic Acid–Based Diagnostic Market Size by Country (2019-2024)
10.4 Middle East & Africa Nucleic Acid–Based Diagnostic Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Detail
11.1.2 Agilent Technologies Business Overview
11.1.3 Agilent Technologies Nucleic Acid–Based Diagnostic Introduction
11.1.4 Agilent Technologies Revenue in Nucleic Acid–Based Diagnostic Business (2019-2024)
11.1.5 Agilent Technologies Recent Development
11.2 Danaher Corporation
11.2.1 Danaher Corporation Company Detail
11.2.2 Danaher Corporation Business Overview
11.2.3 Danaher Corporation Nucleic Acid–Based Diagnostic Introduction
11.2.4 Danaher Corporation Revenue in Nucleic Acid–Based Diagnostic Business (2019-2024)
11.2.5 Danaher Corporation Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Detail
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories Nucleic Acid–Based Diagnostic Introduction
11.3.4 Abbott Laboratories Revenue in Nucleic Acid–Based Diagnostic Business (2019-2024)
11.3.5 Abbott Laboratories Recent Development
11.4 BD
11.4.1 BD Company Detail
11.4.2 BD Business Overview
11.4.3 BD Nucleic Acid–Based Diagnostic Introduction
11.4.4 BD Revenue in Nucleic Acid–Based Diagnostic Business (2019-2024)
11.4.5 BD Recent Development
11.5 Bio-Rad Laboratories
11.5.1 Bio-Rad Laboratories Company Detail
11.5.2 Bio-Rad Laboratories Business Overview
11.5.3 Bio-Rad Laboratories Nucleic Acid–Based Diagnostic Introduction
11.5.4 Bio-Rad Laboratories Revenue in Nucleic Acid–Based Diagnostic Business (2019-2024)
11.5.5 Bio-Rad Laboratories Recent Development
11.6 Roche
11.6.1 Roche Company Detail
11.6.2 Roche Business Overview
11.6.3 Roche Nucleic Acid–Based Diagnostic Introduction
11.6.4 Roche Revenue in Nucleic Acid–Based Diagnostic Business (2019-2024)
11.6.5 Roche Recent Development
11.7 Illumina, Inc
11.7.1 Illumina, Inc Company Detail
11.7.2 Illumina, Inc Business Overview
11.7.3 Illumina, Inc Nucleic Acid–Based Diagnostic Introduction
11.7.4 Illumina, Inc Revenue in Nucleic Acid–Based Diagnostic Business (2019-2024)
11.7.5 Illumina, Inc Recent Development
11.8 Thermo Fisher Scientific Inc.
11.8.1 Thermo Fisher Scientific Inc. Company Detail
11.8.2 Thermo Fisher Scientific Inc. Business Overview
11.8.3 Thermo Fisher Scientific Inc. Nucleic Acid–Based Diagnostic Introduction
11.8.4 Thermo Fisher Scientific Inc. Revenue in Nucleic Acid–Based Diagnostic Business (2019-2024)
11.8.5 Thermo Fisher Scientific Inc. Recent Development
11.9 Merck KGaA
11.9.1 Merck KGaA Company Detail
11.9.2 Merck KGaA Business Overview
11.9.3 Merck KGaA Nucleic Acid–Based Diagnostic Introduction
11.9.4 Merck KGaA Revenue in Nucleic Acid–Based Diagnostic Business (2019-2024)
11.9.5 Merck KGaA Recent Development
11.10 Qiagen
11.10.1 Qiagen Company Detail
11.10.2 Qiagen Business Overview
11.10.3 Qiagen Nucleic Acid–Based Diagnostic Introduction
11.10.4 Qiagen Revenue in Nucleic Acid–Based Diagnostic Business (2019-2024)
11.10.5 Qiagen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Nucleic Acid–Based Diagnostic Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Nucleic Acid Molecular Hybridization
Table 3. Key Players of Polymerase Chain Reaction
Table 4. Key Players of Thermostatic Amplification
Table 5. Key Players of Gene Sequencing
Table 6. Key Players of Biochip Technology
Table 7. Global Nucleic Acid–Based Diagnostic Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Nucleic Acid–Based Diagnostic Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Nucleic Acid–Based Diagnostic Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Nucleic Acid–Based Diagnostic Market Share by Region (2019-2024)
Table 11. Global Nucleic Acid–Based Diagnostic Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Nucleic Acid–Based Diagnostic Market Share by Region (2025-2030)
Table 13. Nucleic Acid–Based Diagnostic Market Trends
Table 14. Nucleic Acid–Based Diagnostic Market Drivers
Table 15. Nucleic Acid–Based Diagnostic Market Challenges
Table 16. Nucleic Acid–Based Diagnostic Market Restraints
Table 17. Global Nucleic Acid–Based Diagnostic Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Nucleic Acid–Based Diagnostic Market Share by Players (2019-2024)
Table 19. Global Top Nucleic Acid–Based Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid–Based Diagnostic as of 2023)
Table 20. Ranking of Global Top Nucleic Acid–Based Diagnostic Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Nucleic Acid–Based Diagnostic Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Nucleic Acid–Based Diagnostic Product Solution and Service
Table 24. Date of Enter into Nucleic Acid–Based Diagnostic Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Nucleic Acid–Based Diagnostic Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Nucleic Acid–Based Diagnostic Revenue Market Share by Type (2019-2024)
Table 28. Global Nucleic Acid–Based Diagnostic Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Nucleic Acid–Based Diagnostic Revenue Market Share by Type (2025-2030)
Table 30. Global Nucleic Acid–Based Diagnostic Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Nucleic Acid–Based Diagnostic Revenue Market Share by Application (2019-2024)
Table 32. Global Nucleic Acid–Based Diagnostic Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Nucleic Acid–Based Diagnostic Revenue Market Share by Application (2025-2030)
Table 34. North America Nucleic Acid–Based Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Nucleic Acid–Based Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Nucleic Acid–Based Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Nucleic Acid–Based Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Nucleic Acid–Based Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Nucleic Acid–Based Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Nucleic Acid–Based Diagnostic Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Nucleic Acid–Based Diagnostic Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Nucleic Acid–Based Diagnostic Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Nucleic Acid–Based Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Nucleic Acid–Based Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Nucleic Acid–Based Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 49. Agilent Technologies Company Detail
Table 50. Agilent Technologies Business Overview
Table 51. Agilent Technologies Nucleic Acid–Based Diagnostic Product
Table 52. Agilent Technologies Revenue in Nucleic Acid–Based Diagnostic Business (2019-2024) & (US$ Million)
Table 53. Agilent Technologies Recent Development
Table 54. Danaher Corporation Company Detail
Table 55. Danaher Corporation Business Overview
Table 56. Danaher Corporation Nucleic Acid–Based Diagnostic Product
Table 57. Danaher Corporation Revenue in Nucleic Acid–Based Diagnostic Business (2019-2024) & (US$ Million)
Table 58. Danaher Corporation Recent Development
Table 59. Abbott Laboratories Company Detail
Table 60. Abbott Laboratories Business Overview
Table 61. Abbott Laboratories Nucleic Acid–Based Diagnostic Product
Table 62. Abbott Laboratories Revenue in Nucleic Acid–Based Diagnostic Business (2019-2024) & (US$ Million)
Table 63. Abbott Laboratories Recent Development
Table 64. BD Company Detail
Table 65. BD Business Overview
Table 66. BD Nucleic Acid–Based Diagnostic Product
Table 67. BD Revenue in Nucleic Acid–Based Diagnostic Business (2019-2024) & (US$ Million)
Table 68. BD Recent Development
Table 69. Bio-Rad Laboratories Company Detail
Table 70. Bio-Rad Laboratories Business Overview
Table 71. Bio-Rad Laboratories Nucleic Acid–Based Diagnostic Product
Table 72. Bio-Rad Laboratories Revenue in Nucleic Acid–Based Diagnostic Business (2019-2024) & (US$ Million)
Table 73. Bio-Rad Laboratories Recent Development
Table 74. Roche Company Detail
Table 75. Roche Business Overview
Table 76. Roche Nucleic Acid–Based Diagnostic Product
Table 77. Roche Revenue in Nucleic Acid–Based Diagnostic Business (2019-2024) & (US$ Million)
Table 78. Roche Recent Development
Table 79. Illumina, Inc Company Detail
Table 80. Illumina, Inc Business Overview
Table 81. Illumina, Inc Nucleic Acid–Based Diagnostic Product
Table 82. Illumina, Inc Revenue in Nucleic Acid–Based Diagnostic Business (2019-2024) & (US$ Million)
Table 83. Illumina, Inc Recent Development
Table 84. Thermo Fisher Scientific Inc. Company Detail
Table 85. Thermo Fisher Scientific Inc. Business Overview
Table 86. Thermo Fisher Scientific Inc. Nucleic Acid–Based Diagnostic Product
Table 87. Thermo Fisher Scientific Inc. Revenue in Nucleic Acid–Based Diagnostic Business (2019-2024) & (US$ Million)
Table 88. Thermo Fisher Scientific Inc. Recent Development
Table 89. Merck KGaA Company Detail
Table 90. Merck KGaA Business Overview
Table 91. Merck KGaA Nucleic Acid–Based Diagnostic Product
Table 92. Merck KGaA Revenue in Nucleic Acid–Based Diagnostic Business (2019-2024) & (US$ Million)
Table 93. Merck KGaA Recent Development
Table 94. Qiagen Company Detail
Table 95. Qiagen Business Overview
Table 96. Qiagen Nucleic Acid–Based Diagnostic Product
Table 97. Qiagen Revenue in Nucleic Acid–Based Diagnostic Business (2019-2024) & (US$ Million)
Table 98. Qiagen Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nucleic Acid–Based Diagnostic Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Nucleic Acid–Based Diagnostic Market Share by Type: 2023 VS 2030
Figure 3. Nucleic Acid Molecular Hybridization Features
Figure 4. Polymerase Chain Reaction Features
Figure 5. Thermostatic Amplification Features
Figure 6. Gene Sequencing Features
Figure 7. Biochip Technology Features
Figure 8. Global Nucleic Acid–Based Diagnostic Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Nucleic Acid–Based Diagnostic Market Share by Application: 2023 VS 2030
Figure 10. Hospital Case Studies
Figure 11. Clinical Laboratory Case Studies
Figure 12. Research Institutions Case Studies
Figure 13. Clinic Case Studies
Figure 14. Other Case Studies
Figure 15. Nucleic Acid–Based Diagnostic Report Years Considered
Figure 16. Global Nucleic Acid–Based Diagnostic Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Nucleic Acid–Based Diagnostic Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Nucleic Acid–Based Diagnostic Market Share by Region: 2023 VS 2030
Figure 19. Global Nucleic Acid–Based Diagnostic Market Share by Players in 2023
Figure 20. Global Top Nucleic Acid–Based Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid–Based Diagnostic as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Nucleic Acid–Based Diagnostic Revenue in 2023
Figure 22. North America Nucleic Acid–Based Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Nucleic Acid–Based Diagnostic Market Share by Country (2019-2030)
Figure 24. United States Nucleic Acid–Based Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Nucleic Acid–Based Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Nucleic Acid–Based Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Nucleic Acid–Based Diagnostic Market Share by Country (2019-2030)
Figure 28. Germany Nucleic Acid–Based Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Nucleic Acid–Based Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Nucleic Acid–Based Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Nucleic Acid–Based Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Nucleic Acid–Based Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Nucleic Acid–Based Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Nucleic Acid–Based Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Nucleic Acid–Based Diagnostic Market Share by Region (2019-2030)
Figure 36. China Nucleic Acid–Based Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Japan Nucleic Acid–Based Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. South Korea Nucleic Acid–Based Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Nucleic Acid–Based Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. India Nucleic Acid–Based Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Australia Nucleic Acid–Based Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Nucleic Acid–Based Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Nucleic Acid–Based Diagnostic Market Share by Country (2019-2030)
Figure 44. Mexico Nucleic Acid–Based Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Brazil Nucleic Acid–Based Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Nucleic Acid–Based Diagnostic Market Share by Country (2019-2030)
Figure 48. Turkey Nucleic Acid–Based Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Nucleic Acid–Based Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Agilent Technologies Revenue Growth Rate in Nucleic Acid–Based Diagnostic Business (2019-2024)
Figure 51. Danaher Corporation Revenue Growth Rate in Nucleic Acid–Based Diagnostic Business (2019-2024)
Figure 52. Abbott Laboratories Revenue Growth Rate in Nucleic Acid–Based Diagnostic Business (2019-2024)
Figure 53. BD Revenue Growth Rate in Nucleic Acid–Based Diagnostic Business (2019-2024)
Figure 54. Bio-Rad Laboratories Revenue Growth Rate in Nucleic Acid–Based Diagnostic Business (2019-2024)
Figure 55. Roche Revenue Growth Rate in Nucleic Acid–Based Diagnostic Business (2019-2024)
Figure 56. Illumina, Inc Revenue Growth Rate in Nucleic Acid–Based Diagnostic Business (2019-2024)
Figure 57. Thermo Fisher Scientific Inc. Revenue Growth Rate in Nucleic Acid–Based Diagnostic Business (2019-2024)
Figure 58. Merck KGaA Revenue Growth Rate in Nucleic Acid–Based Diagnostic Business (2019-2024)
Figure 59. Qiagen Revenue Growth Rate in Nucleic Acid–Based Diagnostic Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
